ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel Clinical and Potency Studies Presented at Tandem
|
|
fluffington
|
217 |
70K |
8 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
217
|
70K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel Clinical and Potency Studies Presented at Tandem
|
|
fluffington
|
217 |
70K |
8 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
217
|
70K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
fluffington
|
17K |
6.7M |
6 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Breakout
|
|
fluffington
|
144 |
48K |
4 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
144
|
48K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
fluffington
|
17K |
6.7M |
3 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
fluffington
|
1.0K |
330K |
5 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
1.0K
|
330K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
fluffington
|
1.0K |
330K |
3 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
1.0K
|
330K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
fluffington
|
1.0K |
330K |
7 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
1.0K
|
330K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
fluffington
|
5.4K |
2.6M |
0 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
5.4K
|
2.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
fluffington
|
9.8K |
2.9M |
1 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
fluffington
|
3.2K |
1.0M |
3 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Scripps Research study identifies existing drugs as potential COVID-19 therapies
|
|
fluffington
|
171 |
49K |
2 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
171
|
49K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
fluffington
|
472 |
182K |
2 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
472
|
182K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
fluffington
|
472 |
182K |
5 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
472
|
182K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
fluffington
|
472 |
182K |
1 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
472
|
182K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
fluffington
|
472 |
182K |
2 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
472
|
182K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
fluffington
|
472 |
182K |
2 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
472
|
182K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
fluffington
|
13K |
6.3M |
1 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
fluffington
|
13K |
6.3M |
6 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
13K
|
6.3M
|
6
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
fluffington
|
13K |
6.3M |
5 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
13K
|
6.3M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
fluffington
|
13K |
6.3M |
3 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
fluffington
|
13K |
6.3M |
1 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
fluffington
|
17K |
6.7M |
3 |
21/05/22 |
21/05/22 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
fluffington
|
13K |
6.3M |
3 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 EFFECTIVE AGAINST ESTABLISHED SARS-CoV-2 IN ANIMALS
|
|
fluffington
|
178 |
73K |
4 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
178
|
73K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
fluffington
|
9.8K |
2.9M |
8 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
8
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Change of ASX Ticker for Zip Co Limited
|
|
fluffington
|
52 |
25K |
6 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
52
|
25K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
fluffington
|
17K |
6.7M |
4 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
fluffington
|
144 |
56K |
3 |
20/03/22 |
20/03/22 |
ASX - By Stock
|
144
|
56K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
fluffington
|
1.0K |
330K |
2 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
1.0K
|
330K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
fluffington
|
505 |
160K |
3 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
505
|
160K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
fluffington
|
1.0K |
330K |
5 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
1.0K
|
330K
|
5
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Trading Halt
|
|
fluffington
|
93 |
39K |
1 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
93
|
39K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Trading Halt
|
|
fluffington
|
93 |
39K |
4 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
93
|
39K
|
4
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Trading Halt
|
|
fluffington
|
93 |
39K |
1 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
93
|
39K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Trading Halt
|
|
fluffington
|
93 |
39K |
0 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
93
|
39K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Trading Halt
|
|
fluffington
|
93 |
39K |
2 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
93
|
39K
|
2
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
fluffington
|
408 |
134K |
0 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
408
|
134K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
fluffington
|
373 |
88K |
6 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
373
|
88K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
fluffington
|
373 |
88K |
11 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
373
|
88K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
fluffington
|
17K |
6.7M |
10 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
17K
|
6.7M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Greatest Benefit in Diabetics and Ischemics
|
|
fluffington
|
304 |
95K |
1 |
20/12/21 |
20/12/21 |
ASX - By Stock
|
304
|
95K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
fluffington
|
4.7K |
1.1M |
4 |
11/12/21 |
11/12/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
fluffington
|
10K |
3.0M |
5 |
04/12/21 |
04/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIOTRON DRUG EFFECTIVE AGAINST COVID-19 IN ANIMALS
|
|
fluffington
|
486 |
136K |
8 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
486
|
136K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
MM's Presentation on recent ANN.
|
|
fluffington
|
26 |
6.6K |
4 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
26
|
6.6K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
fluffington
|
13K |
6.3M |
0 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
13K
|
6.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
MM's Presentation on recent ANN.
|
|
fluffington
|
26 |
6.6K |
0 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
26
|
6.6K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
fluffington
|
13K |
6.3M |
1 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
MM's Presentation on recent ANN.
|
|
fluffington
|
26 |
6.6K |
3 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
26
|
6.6K
|
3
|
|